This is a repository copy of Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
暂无分享,去创建一个
C. Peterfy | M. Genovese | P. Emery | E. Keystone | J. DiCarlo | P. Taylor | S. Beattie | E. Keystone | W. Macias | M. Luchi | D. Schlichting | M. Genovese | MA PCTaylor | RN DESchlichting | S. Beattie | W. Macias